Dr. Jason Acker, MBA, PhD, FCAHS Co-founder of PanTHERA CryoSolutions, a BioLife Solutions Company. He is a distinguished leader in biopreservation, transfusion medicine, and cell therapy manufacturing, with extensive experience bridging scientific research and industry innovation. He has dedicated his career to advancing cryopreservation technologies, blood component processing, and regenerative medicine applications. With a strong background in academic research, regulatory compliance, and technology development, Dr. Acker has contributed to improving the quality, safety, and efficacy of cellular therapies worldwide. His work has led to significant advancements in biobanking, process optimization, and cold chain logistics, ensuring the integrity of biological products from lab to patient.
As cell-based therapies grow more complex and manufacturing networks expand, resilience can’t be an afterthought, and cryopreservation can no longer just be a step that gets validated during development and left alone. It needs to play an ongoing role in product consistency, potency, and reliability.